$22.44
2.39% day before yesterday
Nasdaq, Nov 26, 11:49 pm CET
ISIN
US50015M1099
Symbol
KOD

Kodiak Sciences, Inc. Stock price

$22.44
+3.61 19.17% 1M
+19.00 552.33% 6M
+12.49 125.53% YTD
+15.88 242.07% 1Y
+15.29 213.85% 3Y
-109.76 83.03% 5Y
+12.28 120.87% 10Y
+12.28 120.87% 20Y
Nasdaq, Closing price Wed, Nov 26 2025
-0.55 2.39%
ISIN
US50015M1099
Symbol
KOD
Industry

Key metrics

Basic
Market capitalization
$1.2b
Enterprise Value
$1.1b
Net debt
positive
Cash
$104.2m
Shares outstanding
52.8m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
negative
P/B
16.9
Financial Health
Equity Ratio
44.8%
Return on Equity
-117.3%
ROCE
-92.0%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-189.3m | $-221.7m
EBIT
$-207.8m | $-232.6m
Net Income
$-199.9m | $-218.7m
Free Cash Flow
$-115.8m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
1.8% | -31.8%
EBIT
2.0% | -24.5%
Net Income
-1.2% | -24.1%
Free Cash Flow
27.1%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-3.8
FCF per Share
$-2.2
Short interest
13.7%
Employees
121
Rev per Employee
$0.0
Show more

Is Kodiak Sciences, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,070 stocks worldwide.

Kodiak Sciences, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Kodiak Sciences, Inc. forecast:

6x Buy
55%
4x Hold
36%
1x Sell
9%

Analyst Opinions

11 Analysts have issued a Kodiak Sciences, Inc. forecast:

Buy
55%
Hold
36%
Sell
9%

Financial data from Kodiak Sciences, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 56 56
16% 16%
-
- Research and Development Expense 150 150
3% 3%
-
-189 -189
2% 2%
-
- Depreciation and Amortization 19 19
3% 3%
-
EBIT (Operating Income) EBIT -208 -208
2% 2%
-
Net Profit -200 -200
1% 1%
-

In millions USD.

Don't miss a Thing! We will send you all news about Kodiak Sciences, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Kodiak Sciences, Inc. Stock News

Neutral
PRNewsWire
15 days ago
PALO ALTO, Calif. , Nov. 13, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the third quarter ended September 30, 2025.
Neutral
PRNewsWire
16 days ago
PALO ALTO, Calif. , Nov. 12, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, announced today that Victor Perlroth, M.D.
Neutral
PRNewsWire
23 days ago
Meaningful vision gains are rapidly achieved as early as week 4 and showed continued improvement in best corrected visual acuity (BCVA) through week 20, with more than half of patients achieving improvement of 3-lines or more on the eye chart (≥15 letter gain). ≥90% of patients in the top two dose levels achieved and sustained real dryness of the retina, as demonstrated by absence of intraretin...
More Kodiak Sciences, Inc. News

Company Profile

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapies for the treatment of retinal diseases. Its product pipeline includes KSI-301 for wet AMD; KSI-301 for diabetic eye disease; KSI-501 for DME and uveitis; KSI-201 for resistant wet AMD; and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Head office United States
CEO Victor Perlroth
Employees 121
Founded 2009
Website kodiak.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today